The imperative of clinical and molecular research on neonatal opioid withdrawal syndrome

Affiliations

¹ Department of Molecular and Functional Genomics, Geisinger, Danville, PA, USA.
² Northeastern Pennsylvania Perinatal Quality Collaborative, Geisinger, Danville, PA, USA.
³ Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Cooper School of Medicine, Rowan University, Camden, PA, USA.
⁵ William Beaumont School of Medicine, Oakland University, Oakland, USA.
⁶ Autism and Developmental Medicine Institute, Geisinger, Lewisburg, PA, USA.
⁷ Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wadeb@pennmedicine.upenn.edu.
⁸ Geisinger Clinic, Danville, PA, USA. wadeb@pennmedicine.upenn.edu.

Editorial

Raghu P Metpally et al. Mol Psychiatry. 2019 Nov.

. 2019 Nov;24(11):1568-1571.

doi: 10.1038/s41380-019-0522-1. Epub 2019 Sep 10.

¹ Department of Molecular and Functional Genomics, Geisinger, Danville, PA, USA.
² Northeastern Pennsylvania Perinatal Quality Collaborative, Geisinger, Danville, PA, USA.
³ Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Cooper School of Medicine, Rowan University, Camden, PA, USA.
⁵ William Beaumont School of Medicine, Oakland University, Oakland, USA.
⁶ Autism and Developmental Medicine Institute, Geisinger, Lewisburg, PA, USA.
⁷ Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wadeb@pennmedicine.upenn.edu.
⁸ Geisinger Clinic, Danville, PA, USA. wadeb@pennmedicine.upenn.edu.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare no conflict of interest.

1. Substance Absuse and Mental Health Services Administration, Office of the Surgeon General Publications and Reports of the Surgeon General. Facing addiction in America: the surgeon general’s spotlight on opioids. Washington (DC): US Department of Health and Human Services; 2018.
1. Kiang MV, Basu S, Chen J, Alexander MJ. Assessment of changes in the geographical distribution of opioid-related mortality across the united states by opioid type, 1999–2016. JAMA Netw Open. 2019;2:e190040. - PMC - PubMed
1. Vivolo-Kantor AM, Seth P, Gladden RM, Mattson CL, Baldwin GT, Kite-Powell A, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017. MMWR Morbidity Mortal Wkly Rep. 2018;67:279–85. - PMC - PubMed
1. Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry. 2016;173:18–26. - PMC - PubMed
1. Cheatle MD. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities. Expert Rev Clin Pharm. 2016;9:751–4. - PubMed